Skip to main content

Table 3 Indications for previous use of Kampo medicines

From: Opinions on Kampo and reasons for using it – results from a cross-sectional survey in three Japanese clinics

Treated medical complaint

All

Kampo/CM

Integrative

Kampo

 

% (n)

% (n)

% (n)

% (n)

Common Cold

36.2 (105)

31.2 (29)

27.9 (38)

30.4 (38)

Gastrointestinal Complaints

30.2 (88)

24.7 (23)

17.6 (24)

32.8 (41)

Hi’e-sho *

29.0 (84)

31.2 (29)

12.5 (17)

30.4 (38)

Stress/Anxiety Disorder

20.7 (60)

19.4 (18)

15.4 (21)

16.8 (21)

Shoulder Stiffness

20.3 (59)

25.8 (24)

9.6 (13)

17.6 (22)

Gynaecological Disease

18.2 (53)

14.0 (13)

13.2 (18)

17.6 (22)

Allergy

16.8 (49)

11.8 (11)

7.4 (16)

17.6 (22)

Hay Fever

14.8 (43)

16.1 (15)

8.1 (11)

13.6 (17)

Headache/Migraine

13.1 (38)

17.2 (16)

8.8 (12)

8.0 (10)

Disturbed Sleep

12.0 (35)

10.8 (10)

8.8 (12)

10.4 (13)

Low Back Pain

11.0 (32)

12.9 (12)

2.9 (4)

12.8 (16)

Dermatological Disease

9.7 (28)

7.5 (7)

0.7 (1)

16.0 (20)

Bronchitis

6.9 (20)

4.3 (4)

5.9 (8)

6.4 (8)

Asthma

6.5 (19)

8.6 (8)

3.7 (5)

4.8 (6)

Cystitis

6.2 (18)

6.5 (6)

3.7 (5)

5.6 (7)

Muscular Disease

6.2 (18)

8.6 (8)

2.9 (4)

4.8 (6)

Neuralgia

5.5 (16)

7.5 (7)

2.9 (4)

4.0 (5)

Anaemia

4.5 (13)

5.4 (5)

4.4 (6)

1.6 (2)

Depression

4.5 (13)

2.2 (2)

4.4 (6)

4.0 (5)

Hypertension

3.8 (11)

3.2 (3)

3.7 (5)

2.4 (3)

Kidney Disease

3.4 (10)

3.2 (3)

0.7 (1)

4.8 (6)

Hypotension

3.1 (9)

3.2 (3)

1.5 (2)

3.2 (4)

Obesity

3.1 (9)

2.2 (2)

2.9 (4)

2.4 (3)

Rheumatic Disease

2.7 (8)

3.2 (3)

2.2 (3)

1.6 (2)

Cancer

1.7 (5)

1.1 (1)

0.0 (0)

3.2 (4)

Diabetes

1.7 (5)

1.1 (1)

0.7 (1)

2.4 (3)

Gastric Ulcer

1.7 (5)

1.1 (1)

0.7 (1)

2.4 (3)

Pneumonia

1.7 (5)

2.2 (2)

0.7 (1)

1.6 (2)

Addiction (Alcohol, Drugs, Other)

0.3 (1)

1.1 (1)

0.0 (0)

0.0 (0)

  1. Ailments for which Kampo had been used in the past. Percent of valid answers of Kampo users. CM (traditional) Chinese medicine. * Oversensitivity to cold syndrome, see text.